Search results
Phone: 513-558-4831. Fax: 513-558-4858. frank.mccormack@uc.edu. We conduct both basic and clinical research programs, focused primarily on development of pathogenesis-driven molecular diagnostics and therapeutics for rare lung disease.
- Frank McCormack | Faculty Researchers | Research | Internal ...
1. Solution of the crystal structure of SP-A (with Barbara...
- Francis X. McCormack, MD
Francis X. McCormack, MD. Professor. Division Chief,...
- Frank McCormack | Faculty Researchers | Research | Internal ...
1. Solution of the crystal structure of SP-A (with Barbara Seaton) 2. Characterization of the structure and function relationship of surfactant proteins A (SP-A) and D (SP-D) 3. Development of serum SP-A and VEGF-D as biomarkers in interstitial lung disease. 4. Discovery of direct antimicrobial properties of SP-A and SP-D. 5.
Apr 28, 2011 · Professor and Director, Division of Pulmonary, Critical Care and Sleep Medicine at University of Cincinnati · My clinical research interest id in diffuse parenchymal lung diseases, especially ...
- 500+
- University of Cincinnati
- Arcadia High School
- 855
Francis X. McCormack, MD. Professor. Division Chief, Pulmonary Critical Care and Sleep Medicine; Gordon and Helen Hughes Taylor Chair. Internal Medicine | College of Medicine. Print Full CV. Education/Credentials.
Francis X Mccormack Pulmonary alveolar microlithiasis (PAM) is a fascinating rare lung disease that is associated with the accumulation of hydroxyapatite microliths within the lumen of the ...
Articles 1–20. Division of Pulmonary, Critical Care and Sleep Medicine, The University of Cincinnati - Cited by 20,958 - Genetic interstitial lung diseases - pulmonary alveolar...
People also ask
What does the McCormack laboratory do?
What is McCormack & Trapnell doing?
Who is Aaron Mulhall & Francis X McCormack?
Frank McCormack, MD, is the Scientific Director of The LAM Foundation, a volunteer position he has held for a quarter-century. Over the past 25 years, The LA...
- 55 min
- 357
- lamfoundation